Clinical Trials Logo

Seach Results for — “light therapy”

Ultrasonographic Response to Polarized Light Therapy in the Treatment of Atopic Dermatitis

Ultrasonographic Response to Polarized Light Therapy in the Treatment of Atopic Dermatitis

Non-atopic dermatitis (NAD) or eczema is a common inflammatory condition; potentially debilitating that can compromise quality of life. It is usually seen in childhood, but can onset within or persist into adulthood.

NCT04955951 — Chronic Atopic Dermatitis
Status: Terminated
http://inclinicaltrials.com/chronic-atopic-dermatitis/NCT04955951/

The Circadian Rhythm of ICU Patients With Acute Myocardial Infraction and the Effect of Light Therapy

The Circadian Rhythm of ICU Patients With Acute Myocardial Infraction and the Effect of Dynamic Light Therapy : A Preliminary Study

By using subjective and objective measurements, the investigators monitor the change of circadian rhythm in Intensive Care Unit (ICU) patients with acute myocardial infarction and the effect of light therapy.

NCT04953767 — Delirium
Status: Recruiting
http://inclinicaltrials.com/delirium/NCT04953767/

Bright Light Therapy in Older Adults With Moderate to Very Severe Dementia - BLT-Dementia

Bright Light Therapy in Older Adults With Moderate to Very Severe Dementia: Effects on Cognition, Mood, Behavior, and Physiological Parameters

INTRODUCTION: Bright light therapy (BLT) has demonstrated positive effects on sleep, mood, and behavioral problems in older adults with dementia. However, there is little research in people with advanced stages of dementia. OBJECTIVES: Main objectives are to study the immediate effects, short and long-term effects of BLT in a sample of institutionalized older adults with moderate to very severe dementia. Later, to compare the potential effectiveness of bright light therapy sessions with other non-pharmacological interventions in people with dementia. METHODS AND ANALYSIS: The study was a 2 x 2 randomized controlled trial using a two-group design (BLT vs. control) and two repeated measures (pre- vs. postintervention). In addition, the BLT group participants were assessed immediately before, after, and during each session. The BLT protocol consisted of 30-minute morning sessions of 10,000 lux, Monday through Friday, for 4 weeks. For the statistical analysis, two-way analysis of variance (ANOVA) are used to determine the existence of differences at two points in time (pre- vs. post-). The Wilcoxon signed-rank test or the Paired t test are used to measure changes from before to after the intervention sessions.

NCT04949984 — Dementia
Status: Completed
http://inclinicaltrials.com/dementia/NCT04949984/

Feasibility of Adherence to Light Therapy

A Feasibility Study of Adherence to Light Therapy for Maintenance Treatment of Major Depressive Disorder

In this feasibility study, we propose an important question: What factors will affect participant adherence to the daily use of light therapy for maintenance treatment of depression? To answer this question, we will conduct a pilot study of open-label treatment with light therapy in a small sample (n=10) of participants meeting eligibility criteria to determine what factors will challenge or enhance adherence to a standard light therapy protocol.

NCT04944758 — Major Depression in Remission
Status: Terminated
http://inclinicaltrials.com/major-depression-in-remission/NCT04944758/

Myopia Control Using Bright Light Therapy, Myopic Defocus and Atropine

Effectiveness of Bright Light Therapy, Myopic Defocus, Atropine and the Combinations for Controlling Myopic Eye Growth in Schoolchildren: A Randomized Control Trial

The purpose of the study is to investigate the effect of bright light therapy, myopic defocus, atropine and the combination in myopia control in schoolchildren.

NCT04923841 — Myopia
Status: Recruiting
http://inclinicaltrials.com/myopia/NCT04923841/

Bright Light Therapy for Depression Symptoms in Adults With Cystic Fibrosis (CF) and COPD

Effect of Bright Light Therapy on Depression Symptoms in Adult Inpatients With Cystic Fibrosis (CF) and Chronic Obstructive Pulmonary Disease (COPD)

This is a project that will determine whether the use of daily bright light therapy has an effect on depressive symptoms experienced by adult inpatients with CF and COPD. The purpose of this project is to apply a daily 30-minute BLT intervention to hospitalized adult CF and COPD patients in order to decrease symptoms of depression as measured by depression inventory scoring.

NCT04921332 — Chronic Obstructive Pulmonary Disease
Status: Terminated
http://inclinicaltrials.com/chronic-obstructive-pulmonary-disease/NCT04921332/

Intense Pulsed Light Therapy in Meibomian Gland Dysfunction

Intense Pulsed Light Therapy in the Treatment of Refractory Meibomian Gland Dysfunction

to evaluate the effect of intense pulsed light on resistant patients with Meibomian gland dysfunction

NCT04904874 — Meibomian Gland Dysfunction
Status: Recruiting
http://inclinicaltrials.com/meibomian-gland-dysfunction/NCT04904874/

An Evaluation of Low Level Laser Light Therapy for Autistic Disorder 2

A Double-blind, Placebo-controlled Randomized Evaluation of the Effect of the Erchonia® HLS Laser Device on Children With Autistic Disorder Clinical Study Protocol 2

The purpose of this study is to determine whether the Erchonia HLS Laser is effective in the treatment of irritability associated with autistic disorder in children and adolescents aged five (5) to twelve (12) years.

NCT04895605 — Autistic Disorder
Status: Completed
http://inclinicaltrials.com/autistic-disorder/NCT04895605/

The Effect of Bright Light Therapy on Migraine With Sleep Disturbance

The Effect of Bright Light Therapy on Migraine With Sleep Disturbance: the Role of Circadian Rhythms and Specific Biomarkers

Migraine is a common disabling disorder and its substantial burden is associated with considerable negative impact on quality of life. Several pharmacological treatments are available for migraine prophylaxis but insufficient efficacy and significant side effects preclude them being widely using in migraine treatment. Recently, growing evidences have suggested that migraines are closely associated with sleep and circadian rhythms. Sleep disturbance is well-known as one of the triggers for migraine episode, and too much sleep (i.e., sleeping more on weekend) can also trigger migraine attacks. In addition, shift-work or jet lag have been reported to be triggers in some migraines; regular and good sleep would benefit migraine. Intriguing, hypothalamus is thought to be migraine generator and sleep and circadian activity rhythm also under controlled by hypothalamus. The evidence suggests an influence of both sleep and the circadian system with migraine. In the past, clinical evidence has shown that light therapy can stabilize the sleep architecture and further improve insomnia related to circadian rhythm disorders. However, the beneficial effect of light therapy on migraine with sleep disturbance has not yet been determined. This randomized, double-blinded, placebo-controlled study aim to: 1. Explore the clinical efficacy of bright light therapy for migraine prevention; 2. Explore the underlying molecular and biochemical mechanisms of light therapy on migraine prevention.

NCT04890691 — Migraine
Status: Not yet recruiting
http://inclinicaltrials.com/migraine/NCT04890691/

Repeated Low-Level Red-Light Therapy and Orthokeratology in Fast-progressing Myopia Control

The Multicenter Randomized Clinical Trial of Fast-progressing Myopia Control Using Repeated Low-Level Red-Light Therapy and Orthokeratology

The purpose of this multicenter randomized clinical trial is to evaluate the adjunctive effect of repeated low-level red-light therapy (RLRL) and orthokeratology (ortho-k) on myopia control in ortho-k non-responders who have undergone ortho-k treatment but were still experiencing fast myopia progression.

NCT04722874 — Eye Diseases
Status: Recruiting
http://inclinicaltrials.com/eye-diseases/NCT04722874/